<bill session="110" type="s" number="2311" updated="2009-01-09T16:40:18-05:00">
	<status><introduced date="1194325200" datetime="2007-11-06"/></status>

	<introduced date="1194325200" datetime="2007-11-06"/>
	<titles>
		<title type="short" as="introduced">Non-Prescription Drug Modernization Act of 2007</title>
		<title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.</title>
	</titles>
	<sponsor id="300059"/>
	<cosponsors>

	</cosponsors>
	<actions>
		<action date="1194325200" datetime="2007-11-06"><text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	11/6/2007--Introduced.<br/>Non-Prescription Drug Modernization Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to authorize: (1) the amendment or repeal of an over-the-counter drug monograph without notice and public procedure if there is a finding by the Secretary of Health and Human Services that a category of drugs or a specific drug is associated with a significant risk or that such drugs lack evidence of effectiveness; and (2) the Food and Drug Administration (FDA) to regulate over-the-counter drug advertisements.<br/>Directs the Commissioner of Food and Drugs to identify over-the-counter drug monographs that may require amendment or repeal and to report the findings to Congress.<br/>
	</summary>
</bill>
